arrow
P

Patrice Chevallier

universite de reims champagne-ardenne
H指数:57
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Itacitinib plus calcineurin inhibitor–based therapy for prophylaxis of graft-versus-host disease: GRAVITAS-119 results

伊塔西替尼联合钙调神经磷酸酶抑制剂为基础的治疗预防移植物抗宿主病:GRAVITAS-119研究结果

2026-10-070
PRE
Outcome after first relapse post-immunochemotherapy in older adults with Philadelphia-negative B-cell acute lymphoblastic leukemia: A GRAALL study

免疫化疗后首次复发的费城染色体阴性B细胞急性淋巴细胞白血病患者预后:一项GRAALL研究

Cancer
IF5.1
2026-09-240
PRE
GVHD prophylaxis with PTCy, ATG, PTCy+ATG, or no in vivo T-cell depletion in RIC matched-donor PBSC transplantation for AML and MDS

在AML和MDS的RIC匹配供者PBSC移植中,使用PTCy、ATG、PTCy+ATG或无体内T细胞清除的GVHD预防

2026-09-120
PRE
Allogeneic stem cell transplantation with post-transplantation cyclophosphamide in patients with acute myeloid leukemia achieving first complete remission after one versus two inductions: a study from the ALWP/EBMT

异基因干细胞移植联合移植后环磷酰胺治疗急性髓系白血病患者:单次诱导与两次诱导后达到首次完全缓解的对比研究——来自ALWP/EBMT的研究

2026-09-020
OAAI
Impact of donor and recipient EBV serostatus on transplant outcomes in patients with acute leukemia after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide: Infectious Diseases Working Party EBMT retrospective study

供体和受者EBV血清状态对异基因造血细胞移植后环磷酰胺治疗的急性白血病患者移植结局的影响:EBMT感染性疾病工作组回顾性研究

2026-05-040
PRE
Blinatumomab consolidation for high-risk Ph-negative B-cell acute lymphoblastic leukemia: the GRAALL-2014/B-QUEST study

Blinatumomab巩固治疗高风险Ph阴性B细胞急性淋巴细胞白血病:GRAALL-2014/B-QUEST研究

Blood
IF23.1
2026-04-280
PRE
Impact of stem cell source in HLA-matched hematopoietic stem cell transplant for acute lymphoblastic leukemia in first complete remission: a study from the GRAALL and the SFGM-TC

HLA匹配造血干细胞移植中干细胞来源对首次完全缓解急性淋巴细胞白血病的影响:GRAALL和SFGM-TC的研究

2026-04-160
PRE
Alternative versus matched unrelated donor in adolescents and young adults transplanted for acute myeloid leukemia in first complete remission: A report from the SFGM-TC

替代供者与匹配无关供者在首次完全缓解期接受移植的青少年和年轻急性髓系白血病患者中的比较:SFGM-TC 报告

2026-04-130
PRE
Hematopoietic stem cell transplantation is effective in achieving long-term survival for post-aplastic anemia myeloid neoplasms: the EBMT Severe Aplastic Anemia Report

造血干细胞移植对于实现再生障碍性贫血后髓系肿瘤的长期生存有效:欧洲血液和骨髓移植学会严重再生障碍性贫血报告

2026-01-010
OA
A European survey on allogeneic haematopoietic cell transplantation for myelofibrosis on behalf of the Chronic Malignancies Working Party of the EBMT: focus on ‘real world’ experience of JAK inhibitors, splenomegaly management and novel agents in the transplant algorithm

一项由EBMT慢性恶性疾病工作组代表进行的关于异基因造血细胞移植治疗骨髓纤维化的欧洲调查:聚焦于JAK抑制剂的“真实世界”经验、脾肿大管理以及移植算法中的新型药物

2025-12-240
OAAI
Functional recovery of NK cells after T-cell replete haploidentical HSCT: delayed licensing and poor anti-AML activity

NK细胞在T细胞半相合造血干细胞移植后的功能恢复:延迟的许可和较差的抗AML活性

2025-11-010
OAAI
Age‐adapted chemotherapy and MRD‐oriented transplant for Ph-negative acute lymphoblastic leukemia - GRAALL-2014 trial

年龄适应化疗和微小残留病导向移植治疗Ph阴性急性淋巴细胞白血病——GRAALL-2014试验

Blood
IF23.1
2025-10-280
PRE
Total-body irradiation-based versus chemotherapy alone as myeloablative conditioning regimen prior to hematopoietic allogeneic stem cell transplantation in adults with acute lymphoblastic leukemia: a multi-institutional study from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)

全身照射为基础与单纯化疗作为成人急性淋巴细胞白血病患者造血同种异基因干细胞移植前骨髓清除性预处理方案:一项来自法语区骨髓移植与细胞治疗学会(SFGM-TC)的多中心研究

2025-10-220
PRE
Transplant conditioning intensity (TCI) score predicts allo-HCT outcomes in patients with myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT

移植预处理强度(TCI)评分可预测骨髓纤维化患者的allo-HCT结局:EBMT慢性恶性疾病工作组的研究

2025-10-150
OA
Transplantation in lower risk MDS patients: a prospective phase 2 trial based on donor availability

低风险MDS患者的移植治疗:一项基于供者可及性的前瞻性II期试验

2025-10-100
OAAI
A phase II study of ponatinib for prevention of relapse after allogeneic transplantation in FLT3 internal tandem duplication mutation-positive (FLT3-ITD+) acute myeloid leukemia: the PONALLO trial

一项关于波纳替尼(ponatinib)在FLT3内部串联重复突变阳性(FLT3-ITD+)急性髓系白血病异基因移植后预防复发方面的II期研究:PONALLO试验

2025-10-010
OAAI
Thiotepa-busulfan-fludarabine compared to clofarabine-based conditioning for haploidentical transplant with posttransplant cyclophosphamide in patients with myeloid malignancies: a retrospective study from the SFGM-TC

硫替派-白消安-氟达拉滨与氯法拉滨为基础的预处理方案在异基因移植联合移植后环磷酰胺治疗髓系恶性肿瘤患者中的比较:一项来自SFGM-TC的回顾性研究

2025-09-150
PRE